December 9, 2020 07:17 AM ESTUpdated 07:29 AM
Coronavirus

Covid-19 roundup: UAE claims Sinopharm vac­cine 86% ef­fec­tive, but de­tails are scant; In­dia re­port­ed­ly re­jects As­traZeneca's vac­cine, while UK con­ducts 'all en­com­pass­ing' re­view 

Amber Tong

Nicole DeFeudis

Editor

Over the past month we’ve learned, from Phase III tri­als, how well mR­NA and ade­n­ovirus-based vac­cines pro­tect peo­ple from Covid-19. And now, the first an­nounce­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times